Yield10 Bioscience Inc
NASDAQ:YTEN
Gross Margin
Yield10 Bioscience Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Gross Margin Comparison
Yield10 Bioscience Inc Competitors
Country | US |
Market Cap | 3.7m USD |
Gross Margin |
0%
|
Country | US |
Market Cap | 295.4B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 144.2B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 102.5B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 97.4B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 134.5B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 81.3B USD |
Gross Margin |
78%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 40.6B USD |
Gross Margin |
31%
|
Country | US |
Market Cap | 29.3B USD |
Gross Margin |
74%
|
Country | KR |
Market Cap | 36.9T KRW |
Gross Margin |
48%
|
Profitability Report
View the profitability report to see the full profitability analysis for Yield10 Bioscience Inc.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Yield10 Bioscience Inc's most recent financial statements, the company has Gross Margin of 0%.